A Phase 1, Open-label Study of Oral BDTX-4933 in Patients with KRAS, BRAF and Other Select RAS/MAPK Mutation Positive Neoplasms

Is This Study For You?

Let's Get Started!

Details
Age
Adult
Locations

CTRC Inpatient
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Ross Camidge

Ross Camidge

Study ID

Protocol Number: 23-0675

More information available at ClinicalTrials.gov: NCT05786924

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers